home / stock / eryp / eryp news

ERYP News and Press, Erytech Pharma S.A. From 02/08/21

Stock Information
Company Name: Erytech Pharma S.A.
Stock Symbol: ERYP
Market: NASDAQ
Menu
ERYP ERYP Quote ERYP Short ERYP News ERYP Articles ERYP Message Board
Get ERYP Alerts

News, Short Squeeze, Breakout and More Instantly...
ERYP - OGI, AMC, WPRT and HUYA among midday movers

Gainers: Ocugen (OCGN) +230%.ARYA Sciences Acquisition (ARYA) +101%.CRH Medical (CRHM) +81%.BSQUARE (BSQR) +72%.Esports Entertainment (GMBL) +51%.Outlook Therapeutics (OTLK) +50%.Aeterna Zentaris (AEZS) +46%.Westport Fuel Systems (WPRT) +43%.Nxt-ID (NXTD) +37%.OrganiGram (OGI) +37%....
ERYP - Erytech's late-stage pancreatic cancer study will continue to final analysis

Erytech Pharma's (ERYP) Phase 3 clinical trial TRYbeCA-1, evaluating eryaspase in second-line pancreatic cancer will continue without modification following a planned interim superiority analysis conducted by an Independent Data Monitoring Committee ((IDMC)). The interim analysis was triggere...

ERYP - ERYTECH starts patient enrollment in cancer study

ERYTECH Pharma (ERYP) has announced that the first patient was enrolled in an early-stage investigator-sponsored trial for its lead asset Eryaspase in first-line pancreatic cancer.The single-arm, multi-center, open-label Phase 1 trial, initiated and sponsored by Georgetown University, Wa...

ERYP - ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer

A total of 510 patients enrolled Events required to trigger interim superiority analysis accrued Interim superiority analysis expected in Q1 2021; final analysis in Q4 2021 LYON, France and CAMBRIDGE, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nas...
ERYP - ERYTECH to Present at the JMP Securities Hematology Summit

LYON, France and CAMBRIDGE, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announce d...

ERYP - ERYTECH Announces Positive Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Presented at the American Society of Hematology Annual Meeting

W ebcast today, Monday, December 7 at 4:00 pm CET/10:00 am ET The study confirms the potential of eryaspase as an attractive treatment option for ALL patients with hypersensitivity to PEG-asparaginase LYON, France and CAMBRIDGE, Mass., Dec. 07, 2020 (...

ERYP - ERYTECH Announces Conference Webcast to Discuss Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia to be Presented at the American Society of Hematology 2020 Annual Meeting

LYON, France and CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announce...
ERYP - ERYTECH to Present at Jefferies Virtual Healthcare Conference

LYON, France and CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), announced t o day that its CEO, Gil Beyen, will present an update at the Jefferies Virtual London Healthcare Conference at 12 :00 pm EST / 05:...

ERYP - ERYTECH Pharma's (ERYP) CEO Gil Beyen on Q3 2020 Results - Earnings Call Transcript

ERYTECH Pharma S.A. (ERYP) Q3 2020 Earnings Conference Call November 6, 2020, 8:30 am ET Company Participants Gil Beyen - CEO Iman El-Hariry - CMO Eric Soyer - CFO & COO Conference Call Participants Justin Walsh - JMP Securities Philippa Gardner - Jefferies Ingrid Gafanhão - Kempen F...

ERYP - Erytech Pharma reports 9M results

Erytech Pharma (ERYP): 9M net loss of €53.6MCash and cash equivalents of €40.5M.Press Release For further details see: Erytech Pharma reports 9M results

Previous 10 Next 10